These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17053452)

  • 1. Clinical hemoglobinopathies: iron, lungs and new blood.
    Morris CR; Singer ST; Walters MC
    Curr Opin Hematol; 2006 Nov; 13(6):407-18. PubMed ID: 17053452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure in beta-thalassemia syndromes: a decade of progress.
    Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC
    Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future.
    Bhatia M; Walters MC
    Bone Marrow Transplant; 2008 Jan; 41(2):109-17. PubMed ID: 18059330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
    Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
    Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic transplantation for haemoglobinopathies.
    Vassiliou G; Amrolia P; Roberts IA
    Best Pract Res Clin Haematol; 2001 Dec; 14(4):807-22. PubMed ID: 11924923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.
    Porter JB
    Hemoglobin; 2009; 33 Suppl 1():S37-45. PubMed ID: 20001631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation for children with thalassemia major in China.
    Fang JP; Xu LH
    Pediatr Blood Cancer; 2010 Dec; 55(6):1062-5. PubMed ID: 20979169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice.
    Sii-Felice K; Giorgi M; Leboulch P; Payen E
    Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cord blood stem cell transplantation for haemoglobinopathies.
    Pinto FO; Roberts I
    Br J Haematol; 2008 May; 141(3):309-24. PubMed ID: 18307566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell transplantation and gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Curr Hematol Rep; 2005 Mar; 4(2):126-31. PubMed ID: 15720961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.
    Flanagan JM; Steward S; Hankins JS; Howard TM; Neale G; Ware RE
    Am J Hematol; 2009 Jun; 84(6):328-34. PubMed ID: 19384939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has stem cell transplantation come of age in the treatment of sickle cell disease?
    Shenoy S
    Bone Marrow Transplant; 2007 Nov; 40(9):813-21. PubMed ID: 17704797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia and iron overload.
    Buchbinder D; Nugent D; Vu D; Soni A; Stites J; Hsieh L; Puthenveetil G
    Pediatr Transplant; 2012 May; 16(3):E69-73. PubMed ID: 21108711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of iron overload in thalassemia.
    Cianciulli P
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():208-13. PubMed ID: 19337180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends.
    Smiers FJ; Krishnamurti L; Lucarelli G
    Pediatr Clin North Am; 2010 Feb; 57(1):181-205. PubMed ID: 20307718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalassemia and learning: Neurocognitive functioning in children.
    Armstrong FD
    Ann N Y Acad Sci; 2005; 1054():283-9. PubMed ID: 16339676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of hemoglobinopathies found in Belgium].
    Fondu P
    Bull Mem Acad R Med Belg; 1995; 150(10-11):367-75; discussion 376-8. PubMed ID: 8845787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on thalassemia: clinical care and complications.
    Cunningham MJ
    Pediatr Clin North Am; 2008 Apr; 55(2):447-60, ix. PubMed ID: 18381095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.